{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T04:27:55Z","timestamp":1750307275841,"version":"3.41.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,18]]},"DOI":"10.7759\/cureus.86267","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T10:56:23Z","timestamp":1750244183000},"source":"Crossref","is-referenced-by-count":0,"title":["Keratoacanthoma-Type Invasive Squamous Cell Carcinoma Managed Non-surgically With Topical Immunomodulators"],"prefix":"10.7759","author":[{"given":"Brian A","family":"Moreno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moises","family":"Lutwak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley","family":"Skopit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.08.059","article-title":"Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging","volume":"78","author":"Que SK","year":"2018","unstructured":"Que SK, Zwald FO, Schmults CD. Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging. J Am Acad Dermatol. 2018, 78:237-47. 10.1016\/j.jaad.2017.08.059","journal-title":"J Am Acad Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.06.110","article-title":"Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline","volume":"51","author":"Stratigos A","year":"2015","unstructured":"Stratigos A, Garbe C, Lebbe C, et al.. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline. Eur J Cancer. 2015, 51:1989-2007. 10.1016\/j.ejca.2015.06.110","journal-title":"Eur J Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13180","article-title":"Evidence- and consensus-based (S3) guidelines for the treatment of actinic keratosis - International League of Dermatological Societies in cooperation with the European Dermatology Forum - short version","volume":"29","author":"Werner RN","year":"2015","unstructured":"Werner RN, Stockfleth E, Connolly SM, et al.. Evidence- and consensus-based (S3) guidelines for the treatment of actinic keratosis - International League of Dermatological Societies in cooperation with the European Dermatology Forum - short version. J Eur Acad Dermatol Venereol. 2015, 29:2069-79. 10.1111\/jdv.13180","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200103293441306","article-title":"Cutaneous squamous-cell carcinoma","volume":"344","author":"Alam M","year":"2001","unstructured":"Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med. 2001, 344:975-83. 10.1056\/NEJM200103293441306","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2206348","article-title":"Squamous-cell carcinoma of the skin","volume":"388","author":"Wysong A","year":"2023","unstructured":"Wysong A. Squamous-cell carcinoma of the skin. N Engl J Med. 2023, 388:2262-73. 10.1056\/NEJMra2206348","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2023.101502","article-title":"Recommendations of the International Society of Geriatric Oncology on skin cancer management in older patients","volume":"14","author":"Rembielak A","year":"2023","unstructured":"Rembielak A, Yau T, Akagunduz B, et al.. Recommendations of the International Society of Geriatric Oncology on skin cancer management in older patients. J Geriatr Oncol. 2023, 14:101502. 10.1016\/j.jgo.2023.101502","journal-title":"J Geriatr Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2016.2788","article-title":"Clinical and histological resolution of invasive squamous cell carcinoma by topical imiquimod 3.75%: a case report","volume":"26","author":"Dirschka T","year":"2016","unstructured":"Dirschka T, Schmitz L, Bartha \u00c1. Clinical and histological resolution of invasive squamous cell carcinoma by topical imiquimod 3.75%: a case report. Eur J Dermatol. 2016, 26:408-9. 10.1684\/ejd.2016.2788","journal-title":"Eur J Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2012.1771","article-title":"Successful treatment of two invasive squamous cell carcinomas with topical 5% imiquimod cream in elderly patients","volume":"22","author":"Tiodorovic-Zivkovic D","year":"2012","unstructured":"Tiodorovic-Zivkovic D, Zalaudek I, Longo C, De Pace B, Albertini G, Argenziano G. Successful treatment of two invasive squamous cell carcinomas with topical 5% imiquimod cream in elderly patients. Eur J Dermatol. 2012, 22:579-80. 10.1684\/ejd.2012.1771","journal-title":"Eur J Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.678028","article-title":"Case report: combined intra-lesional IL-2 and topical imiquimod safely and effectively clears multi-focal, high grade cutaneous squamous cell cancer in a combined liver and kidney transplant patient","volume":"12","author":"Vidovic D","year":"2021","unstructured":"Vidovic D, Simms GA, Pasternak S, et al.. Case report: combined intra-lesional IL-2 and topical imiquimod safely and effectively clears multi-focal, high grade cutaneous squamous cell cancer in a combined liver and kidney transplant patient. Front Immunol. 2021, 12:678028. 10.3389\/fimmu.2021.678028","journal-title":"Front Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2011.23.3.357","article-title":"Treatment of keratoacanthoma with 5% imiquimod cream and review of the previous report","volume":"23","author":"Jeon HC","year":"2011","unstructured":"Jeon HC, Choi M, Paik SH, Ahn CH, Park HS, Cho KH. Treatment of keratoacanthoma with 5% imiquimod cream and review of the previous report. Ann Dermatol. 2011, 23:357-61. 10.5021\/ad.2011.23.3.357","journal-title":"Ann Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2006.18.1.14","article-title":"Treatment of keratoacanthoma with 5% imiquimod cream","volume":"1","author":"Ko NY","year":"2006","unstructured":"Ko NY, Park JH, Son SW, et al.. Treatment of keratoacanthoma with 5% imiquimod cream. Ann Dermatol. 2006, 1:14-7. 10.5021\/ad.2006.18.1.14","journal-title":"Ann Dermatol"},{"key":"ref12","article-title":"Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience","volume":"79","author":"Tillman DK Jr","year":"2007","unstructured":"Tillman DK Jr, Carroll MT. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience. Cutis. 2007, 79:241-8.","journal-title":"Cutis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.36849\/JDD.2020.2228","article-title":"Combination topical chemotherapy for the treatment of an invasive cutaneous squamous cell carcinoma","volume":"19","author":"Fayne R","year":"2020","unstructured":"Fayne R, Nanda S, Nichols A, Shen J. Combination topical chemotherapy for the treatment of an invasive cutaneous squamous cell carcinoma. J Drugs Dermatol. 2020, 19:202-4. 10.36849\/JDD.2020.2228","journal-title":"J Drugs Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0109","article-title":"Multiple keratoacanthomas as an untoward response to imiquimod therapy for actinic keratoses","volume":"86","author":"D'Addario S","year":"2006","unstructured":"D'Addario S, Carrington PR. Multiple keratoacanthomas as an untoward response to imiquimod therapy for actinic keratoses. Acta Derm Venereol. 2006, 86:366-7. 10.2340\/00015555-0109","journal-title":"Acta Derm Venereol"},{"key":"ref15","article-title":"Imiquimod for the treatment of Bowen's disease and invasive squamous cell carcinoma","volume":"2","author":"Nouri K","year":"2003","unstructured":"Nouri K, O'Connell C, Rivas MP. Imiquimod for the treatment of Bowen's disease and invasive squamous cell carcinoma. J Drugs Dermatol. 2003, 2:669-73.","journal-title":"J Drugs Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/375404-keratoacanthoma-type-invasive-squamous-cell-carcinoma-managed-non-surgically-with-topical-immunomodulators","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T10:56:24Z","timestamp":1750244184000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/375404-keratoacanthoma-type-invasive-squamous-cell-carcinoma-managed-non-surgically-with-topical-immunomodulators"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.86267","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,18]]}}}